期刊文献+

高孕激素状态下促排卵在多囊卵巢综合征中应用的机制及研究进展

Mechanism and progress for progestin-primed ovarian stimulation protocol in the patients with polycystic ovary syndrome
原文传递
导出
摘要 多囊卵巢综合征(polycystic ovary syndrome,PCOS)是女性最常见的妇科内分泌疾病之一,也是无排卵性不孕的首要原因。与正常排卵女性相比,PCOS患者在辅助生殖治疗中更易面临卵巢过度刺激综合征、卵母细胞质量差和受精失败等问题,因此PCOS患者的促排卵问题备受生殖领域的关注。高孕激素状态下促排卵(progestin-primed ovarian stimulation,PPOS)方案利用外源性孕激素有效阻断黄体生成素峰,达到理想的获卵数、胚胎质量及妊娠结局。本文就PPOS方案对PCOS患者的作用机制、临床应用及发展进行综述。 Polycystic ovary syndrome(PCOS)is one of the most common gynaecological endocrine diseases in women and the main cause of anovulatory infertility.Compared with women with normal ovulation,PCOS patients are more likely to face ovarian hyperstimulation syndrome,poor-quality of oocyte and fertilization failure in assisted reproduction treatment,so ovulation induction in PCOS patients has attracted much attention in the reproductive field.Progestin-primed ovarian stimulation(PPOS)protocol uses exogenous progesterone effectively to block luteinizing hormone surge to achieve ideal number of retrieved oocytes,embryo quality and pregnancy outcomes.This article reviews the mechanism,clinical application and development of PPOS protocol in PCOS patients.
作者 鲍妍婧 李海燕 刘敏茵 欧阳振波 魏世远 高天旸 Bao Yanjing;Li Haiyan;Liu Minyin;Ouyang Zhenbo;Wei Shiyuan;Gao Tianyang(Department of Reproductive Medicine,Guangdong Second Provincial General Hospital,Guangzhou 510317,China)
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2024年第9期963-967,共5页 Chinese Journal of Reproduction and Contraception
关键词 促排卵 黄体期刺激 高孕激素状态下促排卵 受精 体外 胚胎移植 多囊卵巢综合征 Ovarian stimulation Luteal-phase stimulation Progestin-primed ovarian stimulation Fertilization in vitro Embryo transfer Polycystic ovary syndrome
  • 相关文献

参考文献8

二级参考文献72

  • 1The Rotterdam ESHEE/ASRM-Sponsored PCOS Consen- sus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarysyndrome (PCO S ). Fertil Steril, 2004, 81 (1): 19-25.
  • 2Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandro- genic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab, 2006, 91(368):4237-45.
  • 3Swanton A, Story L, Mc Veigh E, et al. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol, 2010, 149(1):68-71.
  • 4Lamazou F, Fuchs F, Grynberg M, et al. Cancellation of IVF- ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? an analysis of 142 cancellations. J Gynecol Obstet Biol Reprod (Paris), 2012, 41(1):41-7.
  • 5Hosseini MA, Aleyasin A, Saeedi H, et al. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles ofpolycystic ovarian syndromepatients. Obstet Gynaecol Res, 2010, 36(3):605-10.
  • 6Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update, 2012, 18(1):73-91.
  • 7Buendgen NK, Schultze-Mosgau A, Cordes T, et al. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study. Arch Gynecol Obstet, 2013, 288 (4):901-4.
  • 8Kuang Y, Hong Q, Chen Q, et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril, 2014, 101(1):105-11.
  • 9March WA, Moore VM, Willson K J, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod, 2010, 25 (2):544-51.
  • 10Rebar R, Judd HL, Yen SS, et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest, 1976, 57(9): 1320-9.

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部